SCHEMBL12801136

SCHEMBL12801136

C=S(Cc1cccc(Nc2nccc(-c3ccc(NC(=O)C4CC4)c(C#N)c3)n2)c1)NCCO

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.44
PDGFRB P09619 2/20 0.44
BCR P11274 2/20 0.44
PDGFRA P16234 2/20 0.44
SRC P12931 1/20 0.44
TBK1 Q9UHD2 7/20 0.43
JAK2 O60674 5/20 0.43
IKBKE Q14164 5/20 0.41
JAK3 P52333 2/20 0.40
HDAC1 Q13547 2/20 0.39
JAK1 P23458 1/20 0.38
PRKCA P17252 1/20 0.38
IKBKB O14920 1/20 0.38
CHUK O15111 1/20 0.38
MAPK8 P45983 1/20 0.38
PIK3CG P48736 1/20 0.38
GSK3B P49841 1/20 0.38
CAMKK2 Q96RR4 1/20 0.38
AURKA O14965 2/20 0.37
LCK P06239 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1667998 0.88 ABL1 (0.46) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL12521980 0.85 ABL1 (0.43) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL12801506 0.83 IKBKE (0.56) TBK1IKBKE
SCHEMBL1667092 0.81 JAK2 (0.50) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL12521971 0.80 JAK2 (0.49) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL13279695 0.77 TBK1 (0.50) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL13279912 0.76 TBK1 (0.52) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL13279852 0.75 TBK1 (0.49) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL13279693 0.75 TBK1 (0.51) ABL1PDGFRBBCRPDGFRASRC
SCHEMBL16132280 0.75 TBK1 (0.47) ABL1PDGFRBBCRPDGFRASRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011046970-A1 AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON MYREXIS, INC. (US) 2011-04-21 WO disclosed